Ernst Boris Chain passed away on August 12, 1978, in Mulgrave, Scotland. His death marked the end of a remarkable career that significantly impacted the fields of medicine and biochemistry. Chain's work on antibiotics, particularly penicillin, alongside Howard Florey and Alexander Fleming, transformed medical treatment by making effective antibacterial drugs widely available. His legacy continues through his contributions to science and his influence on future generations of researchers.

In 1969, Ernst Chain was appointed as a Professor of Biochemistry at Imperial College London. This role allowed Chain to continue his research and teaching, influencing a new generation of scientists. His appointment marked a continuation of his lifelong dedication to advancing the field of biochemistry and was a testament to his reputation and contributions to science. At Imperial College, Chain furthered his research into the biochemical processes of microorganisms.

In 1961, Ernst Chain was instrumental in founding the International Society of Microbial Ecology (ISME), which aimed to advance the study of microbial ecology and its applications. The organization's formation provided a platform for scientists worldwide to collaborate on issues related to microorganisms and their environments. Chain's involvement in ISME showcased his dedication to fostering scientific communities and collaboration, emphasizing the importance of microbial research.

In 1954, Ernst Chain published 'The Production of Microbial Metabolites,' a significant work that contributed to the understanding of how microorganisms produce antibiotics and other important chemicals. This publication showcased Chain's continued commitment to advancing the field of microbiology and biochemistry, building on his previous successes with penicillin. His research has had a lasting impact on both the pharmaceutical industry and scientific research, influencing the development of new antibiotics.

In 1945, Ernst Boris Chain, along with Sir Howard Florey and Alexander Fleming, was awarded the Nobel Prize in Physiology or Medicine for their discovery of penicillin and its curative effect in various infectious diseases. This recognition highlighted their pioneering work in the field of antibiotics, which transformed medical practice and has saved millions of lives worldwide. The Nobel Prize recognized their collaborative effort that turned penicillin into a clinically useful drug.

In 1944, Ernst Chain and Howard Florey published their landmark paper 'The Chemical Structure of Penicillin,' which detailed the biochemistry of this vital antibiotic. This work expanded on Alexander Fleming's initial discovery and provided deep insights into how penicillin functioned at a molecular level. Understanding the chemical structure was crucial for the synthesis and mass production of penicillin, ensuring its effective use in treating bacterial infections. This publication was critical for the subsequent development of antibiotics.

In 1940, Howard Florey and Ernst Chain successfully demonstrated the therapeutic action of penicillin in animals, marking a significant milestone in the development of the antibiotic. This breakthrough proved that penicillin could be used as a safe and effective treatment for bacterial infections, revolutionizing medicine and opening the door to the development of other antibiotics. Their work, based on Alexander Fleming's initial discovery, was crucial in the widespread adoption of penicillin as a treatment.

In 1933, Ernst Chain published his paper 'The Fermentation of Pyruvic Acid to Lactic Acid,' which contributed to the understanding of metabolism in microorganisms. This work was part of Chain's early research that helped lay the groundwork for his later discoveries. The paper highlighted the processes involved in microbial fermentation, a key aspect of biochemistry that Chain would continue to explore throughout his career. His early work in this area helped establish him as a prominent figure in biochemistry.

In 1930, Ernst Boris Chain moved from Germany to England due to the rise of anti-Semitic laws in Germany. At that time, he joined the University of Cambridge, where he started his important work in biochemistry. This move was pivotal for Chain's career, as it allowed him to enter a research environment that led to the discovery of penicillin's properties. Chain's decision to relocate not only affected his own life but also had a significant impact on the field of medicine.

Ernst Boris Chain was born on June 19, 1906, in Berlin, Germany. He was a German biochemist who later became a British citizen. Chain is best known for his work on penicillin, the groundbreaking antibiotic that revolutionized modern medicine. His contributions, along with those of Howard Florey and Alexander Fleming, led to the widespread use of antibiotics and saved countless lives. Chain's early life and education in Germany provided the foundation for his future scientific achievements.